|
RICHARD A. KASLOW, MD, MPH,
is Professor of Epidemiology and International Health,
Medicine and Microbiology at the University of Alabama at Birmingham.
BACKGROUND:
Kaslow conducts research on genetic determinants in HIV/AIDS and
other infectious diseases. Appointed in the Schools of Public Health
and Medicine and as Co-Director of the Clinical Research Training
Program, he teaches the principles and practice of population research.
He received his M.D. and M.P.H. degrees from Harvard University
and is board certified in internal medicine, infectious diseases
and preventive medicine. He spent 8 years with the Centers for Disease
Control and nearly 16 with the National Institute of Allergy and
Infectious Diseases, primarily as Epidemiology and Biometry Branch
Chief. He is a Fellow of the American College of Physicians and
the Infectious Diseases Society of America as well as ACE, and a
member of the Society for Epidemiologic Research and the American
Epidemiological Society along with numerous other professional organizations.
As an ACE Board member and subsequently, Kaslow has served in various
committee and liaison assignments. He was Chair of the Epidemiology
Section in the American Public Health Association. He has participated
in various advisory and review committees for NIH, CDC, FDA and
specialty certifying boards. Other past and current research interests
include nosocomial infections, inflammatory and autoimmune diseases,
Lyme disease, HIV/AIDS and other infections.
|
AARON
BLAIR, PH.D., M.P.H., is Chief of the Occupational
Epidemiology Branch of the National Cancer Institute.
BACKGROUND:
Blair has a Ph.D. in genetics from North Carolina State University
and an M.P.H. in epidemiology from the University of North Carolina.
He has been at the National Cancer Institute since 1976 and Chief
of the occupational unit since 1980. His research as focused on
the cancer risks among farmers and other groups exposed to pesticides,
among workers exposed to organic solvents and other important industrial
chemicals include formaldehyde and acrylonitrile, and methodologic
issues in occupational epidemiology included procedures for developing
quantitative exposure estimates and the impact of misclassification
on risk estimates. Recently he has worked to encourage investigations
of occupational exposures among women and among disadvantaged groups
such as migrant farm workers. Blair has received the NIH Director’s
Award, the PHS Special Recognition Award, and the H.A. Tyroler Distinguished
Alumni Award from the UNC School of Public Health. He is a fellow
in ACE and a member of the American Epidemiological Society.
MARLENE
B. GOLDMAN, Sc.D. is Principal Research Scientist
and Director, Institute for Research on Women’s Health, New
England Research Institutes
BACKGROUND:
Goldman earned master’s and doctoral degrees in epidemiology
from the Harvard School of Public Health. Prior to joining NERI,
she was an Associate Professor of Epidemiology at Harvard where
she taught epidemiologic principles and methods and developed a
program in reproductive epidemiology. Trained as a chronic disease
epidemiologist, she has twenty-eight years of experience in the
design, conduct, and analysis of epidemiologic studies. Her research
interests include the influence of environmental, occupational,
and lifestyle factors on reproduction and the health consequences
of exposure to ionizing radiation. Goldman designed and co-edited
Women and Health, a 100-chapter epidemiology textbook on women’s
health published by Academic Press. The book won the 1999 Award
of Excellence in Medical Science from the Association of American
Publishers. As an active member of ACE, she has been on the Program
Planning Committee for the last two years and is a member of the
Continuing Education Committee. From 1996 to 1999 she was an Epidemiology
Section Councilor and is currently a Governing Councilor for APHA.
Goldman is an associate editor of the American Journal of Epidemiology
and a member of the American Society of Reproductive Medicine and
the Society for Epidemiologic Research.
|
CAMARA
PHYLLIS JONES, MD, MPH, PHD, is Assistant Professor
of Health and Social Behavior and Epidemiology at the Harvard School
of Public Health.
BACKGROUND:
Jones is a methodologist and social epidemiologist whose work focuses
on the impacts of racism on health. She received her B.A. in Molecular
Biology from Wellesley College, her MD from the Stanford University
School of Medicine, and her MPH and PhD in Epidemiology from the
Johns Hopkins School of Hygiene and Public Health. She has completed
residencies in both Family Practice and General Preventive Medicine.
Jones' detailed analysis of systolic blood pressure by "race"
suggests that the cardiovascular aging of black Americans is accelerated
compared to that of white Americans by roughly ten years. She is
developing explicit measures of racism to further explore the basis
of this accelerated aging. Jones has also developed new statistical
methods for simultaneously comparing the shapes, spreads, and locations
of two distributions. These methods enable a population approach
to data analysis in which the whole distribution, not simply the
average value or the proportion of values beyond some threshold,
becomes the object of study.
From January through September, 1999, Jones was based at the Ministry
of Health in Wellington, New Zealand as an Ian Axford Fellow in
Public Policy. There, she researched the question, "Maori-Pakeha
Health Disparities: Can Treaty Settlements Reverse the Impacts of
Racism?" Jones first served the American College of Epidemiology
as a liaison from the Society for Epidemiologic Research to the
College's Minority Affairs Committee. At the 1999 annual meeting
of the College, Jones was one of the two plenary debaters speaking
in favor of the motion, "Epidemiologists should engage in public
health policy." Jones currently serves on the Board of Directors
of both the Cambridge Public Health Commission and the National
Black Women's Health Project.
CARLOS A. CAMARGO, MD, DrPH,
is a Research Epidemiologist at the Channing Laboratory, Brigham
and Women’s Hospital; Emergency Physician at the Massachusetts
General Hospital; and Assistant Professor of Medicine at Harvard
Medical School.
BACKGROUND:
Dr Camargo’s interest in epidemiology began in college when
he led several alcohol studies at the Stanford Center for Research
in Disease Prevention. He later received an MPH in epidemiology
from UC Berkeley, an MD from UC San Francisco, and did his residency
at the Massachusetts General Hospital in Boston. He then did a research
fellowship in cardiovascular epidemiology at the Brigham and Women’s
Hospital, and earned a DrPH in epidemiology from the Harvard School
of Public Health. Currently, Dr Camargo works clinically in an urban
emergency department, and has focused his research on asthma/COPD.
He serves as PI of the Multicenter Airway Research Collaboration
(MARC), a network of >100 North American emergency departments
(http://healthcare.partners.org/marc). MARC has provided unique
data on asthma among minority populations, and led to the creation
of a new network focusing on patient advocacy issues and how to
increase timely access to primary care. Dr Camargo also is PI of
several large cohort studies looking at risk factors for asthma/COPD
in approximately 350,000 men and women. Dr Camargo’s work
is funded by grants from the NIH, industry, and private foundations
(e.g., EMF Center of Excellence Award). He is an active contributor
to the scientific literature, editorial board member, and performs
peer review for more than a dozen journals. He is a member of the
Cochrane Collaboration, and the National Asthma Education and Prevention
Program (NAEPP) Coordinating Committee.
|